Antimalarial Activity of Aspilia pruliseta, a Medicinal Plant from Uganda

Department of Pharmaceutical Sciences, College of Pharmacy, University of Hawaii at Hilo, Hilo, Hawaii 96720, USA.
Planta Medica (Impact Factor: 2.34). 11/2010; 76(16):1870-3. DOI: 10.1055/s-0030-1250028
Source: PubMed

ABSTRACT Aspilia pruliseta Schweinf. (Asteraceae) is a medicinal plant indigenous to Uganda and the neighboring countries of East Africa. It has been used extensively by the rural population for the treatment of fevers and malaria. During the antimalarial evaluation of this plant, four nontoxic diterpenes were isolated that possessed moderate activity against chloroquine-sensitive (D6) and chloroquine-resistant (W2) clones of Plasmodium falciparum, with IC(50) values ranging from 14 to 23 µM. These moderately active compounds included the previously undescribed diterpene, ENT-15 β-senecioyloxy-16,17-epoxy-kauran-18-oic acid that demonstrated an IC(50) value of 23.4 µM against clone D6, but was devoid of activity against clone W2. Four additional diterpenes were obtained from the aerial parts of A. pruliseta, but these known compounds were essentially inactive. The moderate activities of select diterpenes of A. pruliseta could account collectively for the historical and enduring use of this plant in traditional African medicine.

Download full-text


Available from: Ghee T. Tan, Jun 27, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Acanthaceae and Asteraceae family plants used by folk medicinal practitioners for treatment of malaria in Chittagong and Sylhet Divisions of Bangladesh ABSTRACT Malaria is a debilitating disease causing high mortality rates among men and women if not treated properly. The disease is prevalent in many countries of the world with the most prevalence noted among the sub-Saharan countries, where it is in an epidemic form. The disease is classified as hypo-endemic in Bangladesh with the southeast and the northeastern regions of the country having the most malaria-affected people. The rural people suffer most from malaria, and they rely on folk medicinal practitioners for treatment, who administer various plant species for treatment of the disease as well as associated symptoms like pain and fever. Plant species have always formed the richest sources of anti-malarial drugs, the most notable being quinine and artemisinin. However, quinine has developed drug-resistant vectors and artemisinin is considered by some to developing initial resistance, particularly in China, where it has been used for thousands of years to combat malaria. Thus new sources of anti-malarial drugs need to be found before artemisinin develops drug-resistance, and plant species can form the easiest sources for exploring and discovering new anti-malarial drugs. Since Acanthaceae and Asteraceae family plants have been reported to be excellent families of plants with a number of species demonstrating anti-malarial properties, the objective of the present study was to conduct an ethnomedicinal survey among the folk medicinal practitioners of Chittagong and Sylhet Divisions Bangladesh for these two family species, which are used by the practitioners for treatment of malaria. Three plant species belonging to the Acanthaceae family and five plant species belonging to the Asteraceae family were observed by the folk medicinal practitioners of Bangladesh for malaria treatment. The Acanthaceae family plants were Andrographis paniculata, Justicia adhatoda, and Justicia aurea. The Asteraceae family plants were Blumea lacera, Eclipta alba, Helianthus annuus, Parthenium hysterophorus, and Siegesbeckia orientalis. A perusal of the scientific literature demonstrated that a number of plants in use in Bangladesh as anti-malarials have been reported to contain relevant bio-activities which can justify the use of these species for malaria treatment. Taken together, the plants used in Bangladesh as anti-malarials deserve further scientific study towards discovery of novel anti-malarial drugs.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The emergence and spread of Plasmodium falciparum with resistance to chloroquine (CQ), the safest and cheapest anti-malarial drug, coupled with the increasing cost of alternative drugs especially in developing countries have necessitated the urgent need to tap the potential of plants for novel anti-malarials. The present study investigates the anti-malarial activity of the methanolic extracts of 13 medicinal plants from the Malaiyur and Javadhu hills of South India against blood stage CQ-sensitive (3D7) and CQ-resistant (INDO) strains of P. falciparum in culture using the fluorescence-based SYBR Green I assay. Sorbitol-synchronized parasites were incubated under normal culture conditions at 2% hematocrit and 1% parasitemia in the absence or presence of increasing concentrations of plant extracts. CQ and artemisinin were used as positive controls, while 0.4% DMSO was used as the negative control. The cytotoxic effects of extracts on host cells were assessed by functional assay using HeLa cells cultured in RPMI containing 10% fetal bovine serum, 0.21% sodium bicarbonate and 50 μg/mL gentamycin (complete medium). Plant extracts (bark methanol extracts of Annona squamosa (IC(50), 30 μg/mL), leaf extracts of Ocimum gratissimum (IC(50), 32 μg/mL), Ocimum tenuiflorum (IC(50), 31 μg/mL), Solanum torvum (IC(50), 31 μg/mL) and Justicia procumbens (IC(50), 63 μg/mL), showed moderate activity. The leaf extracts of Aristolochia indica (IC(50), 10 μg/mL), Cassia auriculata (IC(50), 14 μg/mL), Chrysanthemum indicum (IC(50), 20 μg/mL) and Dolichos biflorus (IC(50), 20 μg/mL) showed promising activity and low activity was observed in the flower methanol extracts of A. indica , leaf methanol extract of Catharanthus roseus, and Gymnema sylvestre (IC(50), >100 μg/mL). These four extracts exhibited promising IC(50) (μg/mL) of 17, 24, 19 and 24 respectively also against the CQ resistant INDO strain of P. falciparum. The high TC(50) in mammalian cell cytotoxicity assay and the low IC(50) in anti-malarial P. falciparum assay indicates selectivity and good resistance indices in the range of 0.9-1.7 for leaf extracts of A. indica, C. auriculata, C. indicum and D. biflorus suggests that these may serve as anti-malarial agents even in their crude form. These results indicate a possible explanation of the traditional use of some of these medicinal plants against malaria or malaria-like conditions.
    Parasitology Research 06/2011; 111(2):703-15. DOI:10.1007/s00436-011-2457-6 · 2.33 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Infections with protozoan parasites are a major cause of disease and mortality in many tropical countries of the world. Diseases caused by species of the genera Trypanosoma (Human African Trypanosomiasis and Chagas Disease) and Leishmania (various forms of Leishmaniasis) are among the seventeen "Neglected Tropical Diseases" (NTDs) defined as such by WHO due to the neglect of financial investment into research and development of new drugs by a large part of pharmaceutical industry and neglect of public awareness in high income countries. Another major tropical protozoan disease is malaria (caused by various Plasmodium species), which -although not mentioned currently by the WHO as a neglected disease- still represents a major problem, especially to people living under poor circumstances in tropical countries. Malaria causes by far the highest number of deaths of all protozoan infections and is often (as in this review) included in the NTDs. The mentioned diseases threaten many millions of lives world-wide and they are mostly associated with poor socioeconomic and hygienic environment. Existing therapies suffer from various shortcomings, namely, a high degree of toxicity and unwanted effects, lack of availability and/or problematic application under the life conditions of affected populations. Development of new, safe and affordable drugs is therefore an urgent need. Nature has provided an innumerable number of drugs for the treatment of many serious diseases. Among the natural sources for new bioactive chemicals, plants are still predominant. Their secondary metabolism yields an immeasurable wealth of chemical structures which has been and will continue to be a source of new drugs, directly in their native form and after optimization by synthetic medicinal chemistry. The current review, published in two parts, attempts to give an overview on the potential of such plant-derived natural products as antiprotozoal leads and/or drugs in the fight against NTDs.
    Current Medicinal Chemistry 03/2012; 19(14):2128-75. · 3.72 Impact Factor